Press Releases

Media Focus

Meeting manufacturing demand in the new era of mRNA technologies

Media Focus - Meeting manufacturing demand in the new era of mRNA technologies

Representing a versatile treatment modality for a variety of indications, messenger RNA (mRNA) technologies have paved the way for a new era of biotherapeutics used for therapeutic protein replacement, gene editing, cell therapy, vaccines, cancer therapy, and more over the last five years. Recognizing the transformative potential of mRNA-based medicines, it is even considered as the most suitable modality for the personalized therapeutics, and the biopharma industry has invested heavily in RNA technologies to support growing demand.

Read more

Media Focus - Meeting manufacturing demand in the new era of mRNA technologies

Representing a versatile treatment modality for a variety of indications, messenger RNA (mRNA) technologies have paved the way for a new era of biotherapeutics used for therapeutic protein replacement, gene editing, cell therapy, vaccines, cancer therapy, and more over the last five years. Recognizing the transformative potential of mRNA-based medicines, it is even considered as the most suitable modality for the personalized therapeutics, and the biopharma industry has invested heavily in RNA technologies to support growing demand.

Read more  

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION